日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review

亚洲阵发性睡眠性血红蛋白尿患者血栓栓塞的预防和管理：叙述性综述

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26062504
Ueda, Yasutaka; Chou, Wen-Chien; Goh, Yeow-Tee; Rojnuckarin, Ponlapat; Kim, Jin Seok; Wong, Raymond Siu Ming; Lee Wong, Lily Lee; Jang, Jun Ho; Chiou, Tzeon-Jye; Kanakura, Yuzuru; Lee, Jong Wook
心血管
发表日期：2025
文献求助 收藏

Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan

在接受培塞他考普兰治疗的阵发性睡眠性血红蛋白尿成年患者中，疗效和安全性维持长达3年。

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03310-8
de Castro, Carlos; Kelly, Richard J; Griffin, Morag; Patriquin, Christopher J; Mulherin, Brian; Höchsmann, Britta; Selvaratnam, Veena; Wong, Raymond Siu Ming; Hillmen, Peter; Horneff, Regina; Uchendu, Uchendu O; Zhang, Yiwei; Surova, Elena; Szamosi, Johan; de Latour, Regis Peffault
发表日期：2025
文献求助 收藏

Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation

慢性期CML后期治疗管理：香港共识建议

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06416-9
Cheung, Carol Yuk Man; Ha, Chung Yin; Kho, Bonnie; Lau, Chi Kuen; Lau, June Sze Man; Lin, Shek Ying; Mak, Vivien Wai Man; Wong, Raymond Siu Ming; Kwong, Yok Lam
发表日期：2025
文献求助 收藏

Safety, Efficacy, and Patient-Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria

一项评估波泽利单抗和西美沙酮联合治疗阵发性睡眠性血红蛋白尿患者的 II 期随机试验的安全性、有效性和患者报告结局

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.70095
Jang, Jun-Ho; Wong, Raymond Siu Ming; Hartford, Christopher; Pavani, Rodrigo; Aurand, Lisa; Nguyen, Quang; Mohan, Kosalai; Meagher, Karoline; Sherman, Steven; Rofail, Diana; Perlee, Lorah; Souttou, Amal; Kelly, Richard J
发表日期：2025
文献求助 收藏

Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group

泛太平洋多发性骨髓瘤工作组关于复发/难治性多发性骨髓瘤临床实践中抗CD38疗法的共识指南和建议

期刊:Clinical Hematology International
影响因子:
doi:10.46989/001c.141401
Chen, Wenming; Cai, Zhen; Chim, Chor Sang; Chng, Wee Joo; Du, Juan; Fu, Chengcheng; Gao, Wen; Hanamura, Ichiro; Hou, Jian; Huang, Jeffrey Shang-Yi; Ishida, Tadao; Li, Chunrui; Liu, Aijun; Ptushkin, Vadim; Takezako, Naoki; Wong, Raymond Siu Ming; Yoon, Dok Hyun
多发性骨髓瘤
CD3
CD38
骨髓瘤
发表日期：2025
文献求助 收藏

Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group

CD38单克隆抗体四联疗法在初诊多发性骨髓瘤临床实践中的应用及管理共识指南和建议：来自泛太平洋多发性骨髓瘤工作组

期刊:Clinical Hematology International
影响因子:
doi:10.46989/001c.133682
Chen, Wenming; Cai, Zhen; Chim, James Cs; Chng, Wee Joo; Du, Juan; Fu, Chengcheng; Hanamura, Ichiro; Hou, Jian; Huang, Jeffrey Shang-Yi; Ishida, Tadao; Liu, Aijun; Ptushkin, Vadim; Semenova, Anastasiya; Takezako, Naoki; Wong, Raymond Siu Ming
单克隆抗体
多发性骨髓瘤
CD3
CD38
骨髓瘤
发表日期：2025
文献求助 收藏

C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma.

端结合蛋白 2 是一种新型肿瘤抑制因子，靶向多发性骨髓瘤中的 MYC-IRF4 轴

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010218
Cheung Coty Hing Yau, Cheng Chi Keung, Leung Kam Tong, Zhang Chi, Ho Chi Yan, Luo Xi, Kam Angel Yuet Fong, Xia Tian, Wan Thomas Shek Kong, Pitts Herbert Augustus, Chan Natalie Pui Ha, Cheung Joyce Sin, Wong Raymond Siu Ming, Zhang Xiao-Bing, Ng Margaret Heung Ling
肿瘤
骨髓瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus

亚洲再生障碍性贫血患者阵发性睡眠性血红蛋白尿的监测与治疗：专家共识

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms252212160
Wong, Raymond Siu Ming; Ho Jang, Jun; Wong, Lily Lee Lee; Kim, Jin Seok; Rojnuckarin, Ponlapat; Goh, Yeow-Tee; Ueda, Yasutaka; Chou, Wen-Chien; Lee, Jong Wook; Kanakura, Yuzuru; Chiou, Tzeon-Jye
贫血
代谢
发表日期：2024
文献求助 收藏

Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors

对于接受过依库珠单抗治疗或未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症伴轻度或中度贫血（血红蛋白≥10 g/dL）患者，使用培塞他考普兰可改善血液学指标并减轻疲劳。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0306407
Panse, Jens; Daguindau, Nicolas; Okuyama, Sonia; Peffault de Latour, Régis; Schafhausen, Philippe; Straetmans, Nicole; Al-Adhami, Mohammed; Persson, Emmelie; Wong, Raymond Siu Ming
代谢
贫血
免疫/内分泌
发表日期：2024
文献求助 收藏

An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome

一例罕见的成人斯蒂尔病合并抗补体因子H抗体相关非典型溶血性尿毒综合征病例

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-024-03548-4
Fung, Winston Wing-Shing; Chao, Amelia Chien-Wei; Pang, Wing-Fai; Wong, Raymond Siu-Ming; Chow, Kai-Ming; Szeto, Cheuk-Chun
免疫/内分泌
发表日期：2024
文献求助 收藏